{"id":"group-c-standard-of-care","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a trial designation used at Göteborg University to denote the control or comparator group receiving standard treatment for a given condition. Without specification of the actual therapeutic agent or condition being studied, no mechanistic details can be provided. The specific mechanism would depend entirely on what standard-of-care therapy is being used in that particular trial.","oneSentence":"Group C represents a standard-of-care control arm in a clinical trial, not a specific drug with a defined mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:14:27.129Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT04077463","phase":"PHASE1","title":"A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-09-04","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":701},{"nctId":"NCT07460154","phase":"NA","title":"Structured Review: To Optimise Management and Prevent Harm in COPD","status":"NOT_YET_RECRUITING","sponsor":"Northumbria Healthcare NHS Foundation Trust","startDate":"2026-03-01","conditions":"COPD","enrollment":96},{"nctId":"NCT07460934","phase":"NA","title":"Effect of Pleuran on the Clinical Course of Patients With Chronic Rhinosinusitis","status":"COMPLETED","sponsor":"Pleuran, s.r.o.","startDate":"2022-11-01","conditions":"Chronic Rhinosinusitis (CRS), Exacerbations, Respiratory Tract Infections (RTI)","enrollment":85},{"nctId":"NCT03226418","phase":"PHASE2","title":"Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2017-07-07","conditions":"Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia","enrollment":75},{"nctId":"NCT06780202","phase":"PHASE2","title":"Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-27","conditions":"Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury","enrollment":180},{"nctId":"NCT05540340","phase":"PHASE1","title":"A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2022-09-09","conditions":"Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell","enrollment":39},{"nctId":"NCT06640478","phase":"NA","title":"A 12-week Pilot Nutrition Intervention for Children With New Diagnosis of Stage 3 Type 1 Diabetes (T1D)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2024-11-20","conditions":"Type 1 Diabetes","enrollment":20},{"nctId":"NCT04701437","phase":"NA","title":"Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2021-12-17","conditions":"Hepatitis C","enrollment":80},{"nctId":"NCT04343573","phase":"PHASE2","title":"Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2020-04-10","conditions":"Leptomeningeal Metastases","enrollment":102},{"nctId":"NCT04293562","phase":"PHASE3","title":"A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-07-21","conditions":"Acute Myeloid Leukemia","enrollment":1186},{"nctId":"NCT06505993","phase":"NA","title":"Addressing COVID-19 Vaccine Hesitancy With Muliti-Level Interventions in Appalachia","status":"SUSPENDED","sponsor":"Marc Kiviniemi","startDate":"2026-09","conditions":"COVID-19, Vaccine Hesitancy","enrollment":2250},{"nctId":"NCT06055296","phase":"NA","title":"Multisite Implementation of COMPRENDO","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-01-11","conditions":"Pediatric Cancer","enrollment":450},{"nctId":"NCT06995924","phase":"NA","title":"Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2025-11-17","conditions":"Stage I Colorectal Cancer AJCC v8, Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8","enrollment":75},{"nctId":"NCT07257822","phase":"NA","title":"The Digital Diabetes Patient Reminder (DIPAR) Tool For Adults With Type 2 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"KU Leuven","startDate":"2025-10-06","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":200},{"nctId":"NCT06111313","phase":"PHASE2","title":"The University of Miami Adapt (UAdapt) Trial","status":"RECRUITING","sponsor":"University of Miami","startDate":"2024-11-06","conditions":"Prostate Cancer","enrollment":130},{"nctId":"NCT03101748","phase":"PHASE1, PHASE2","title":"Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2018-02-19","conditions":"Breast Inflammatory Carcinoma, Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma","enrollment":34},{"nctId":"NCT07261254","phase":"NA","title":"Integrating Systems and Basic Income: Improving Outcomes for Families of Young Children","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-04-07","conditions":"Income, Infant, Newborn, Mothers","enrollment":2400},{"nctId":"NCT01775072","phase":"","title":"Genomic Profiling in Cancer Patients","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2013-01","conditions":"Solid Tumors, Hematologic Cancers","enrollment":200},{"nctId":"NCT06429332","phase":"PHASE4","title":"International Care Bundle Evaluation in Cerebral Hemorrhage Research","status":"RECRUITING","sponsor":"Region Skane","startDate":"2025-01-07","conditions":"Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage","enrollment":3500},{"nctId":"NCT03686202","phase":"PHASE2, PHASE3","title":"Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2018-11-30","conditions":"All Solid Tumors","enrollment":65},{"nctId":"NCT07287332","phase":"NA","title":"BLOOM: Pragmatic Feasibility Trial","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-15","conditions":"Sepsis, Infection","enrollment":300},{"nctId":"NCT07369258","phase":"NA","title":"Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit","status":"RECRUITING","sponsor":"HOSPITAL BRITANICO DE BUENOS AIRES","startDate":"2026-02-02","conditions":"Critical Illness, Delirium","enrollment":330},{"nctId":"NCT06941324","phase":"NA","title":"Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors","status":"RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2025-06-23","conditions":"Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","enrollment":60},{"nctId":"NCT07034690","phase":"PHASE4","title":"Study to Evaluate the Impact of a Targeted Lipid Optimization Program on LDL-C Control in At-risk Adult Patients With Dyslipidemia","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2025-11-26","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":326},{"nctId":"NCT06072482","phase":"PHASE4","title":"A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis","status":"RECRUITING","sponsor":"Amgen","startDate":"2024-02-07","conditions":"Antineutrophil Cytoplasmic Antibody-associated Vasculitis","enrollment":300},{"nctId":"NCT06239272","phase":"PHASE1, PHASE2","title":"NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2024-03-27","conditions":"Adipocytic Neoplasm, Liposarcoma, Atypical Fibroxanthoma","enrollment":139},{"nctId":"NCT06565156","phase":"NA","title":"Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioStem Technologies","startDate":"2024-10-28","conditions":"Non-infected Diabetic Foot Ulcer, Diabetic Foot, Diabetic Wound","enrollment":72},{"nctId":"NCT03406884","phase":"PHASE1","title":"The CHILD Trial: Hypoplastic Left Heart Syndrome Study.","status":"COMPLETED","sponsor":"Joshua M Hare","startDate":"2019-10-16","conditions":"Hypoplastic Left Heart Syndrome","enrollment":25},{"nctId":"NCT06511596","phase":"NA","title":"A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC","status":"COMPLETED","sponsor":"BioStem Technologies","startDate":"2024-09-03","conditions":"Diabetic Foot Ulcer","enrollment":71},{"nctId":"NCT06811909","phase":"NA","title":"Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC","status":"RECRUITING","sponsor":"BioStem Technologies","startDate":"2025-02-14","conditions":"Non-infected Venous Leg Ulcer, Venous Leg Ulcer, Venous Insufficiency","enrollment":60},{"nctId":"NCT06284408","phase":"NA","title":"Centralized Screening Unit (CSU) at Montefiore-Einstein","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2025-02-24","conditions":"Lung Cancer","enrollment":9460},{"nctId":"NCT06958107","phase":"","title":"LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-08-21","conditions":"Sarcoma","enrollment":300},{"nctId":"NCT03020030","phase":"PHASE3","title":"Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2017-03-03","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":560},{"nctId":"NCT05796388","phase":"NA","title":"A Study of Virtual Reality and Linaclotide for IBS-C","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-05-31","conditions":"Irritable Bowel Syndrome With Constipation","enrollment":65},{"nctId":"NCT07342543","phase":"NA","title":"Guided Physical Activity Counseling for Hypertension in Primary Care","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Diego","startDate":"2026-10-01","conditions":"Physical Activity, Hypertension, Prehypertension","enrollment":330},{"nctId":"NCT07341217","phase":"NA","title":"Chemo Brain Prehab Project","status":"NOT_YET_RECRUITING","sponsor":"Dr. Chris Gaffney","startDate":"2026-01-30","conditions":"Colorectal Cancer, Older Adults (60 - 85 Years Old), Physically Inactive","enrollment":86},{"nctId":"NCT07001371","phase":"NA","title":"Emotional Brain Training for Addiction Medicine Treatment - A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"Loma Linda University","startDate":"2026-03","conditions":"Cannabis Use Disorder, Stimulant Use Disorder, Opioid Use Disorder","enrollment":54},{"nctId":"NCT05600621","phase":"NA","title":"Suubi+Adherence4Youth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2023-06-26","conditions":"HIV","enrollment":576},{"nctId":"NCT05826964","phase":"PHASE2","title":"Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2023-06-12","conditions":"Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer","enrollment":24},{"nctId":"NCT07334522","phase":"NA","title":"Virtual Reality Distraction for Pain and Anxiety in Hemodialysis Patients","status":"NOT_YET_RECRUITING","sponsor":"Karbala University","startDate":"2025-12-25","conditions":"Pain Management","enrollment":150},{"nctId":"NCT07331246","phase":"NA","title":"TENS for Pain Relief During Fusion-Guided Prostate Biopsy","status":"COMPLETED","sponsor":"Medical University of Gdansk","startDate":"2023-12-01","conditions":"Prostate Cancer, Prostate Biopsy, Fusion Biopsy","enrollment":84},{"nctId":"NCT07330323","phase":"NA","title":"CARES : Customized Aftercare Report for Evaluated Skin Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2026-01","conditions":"Management, Low Risk, Skin Cancer","enrollment":150},{"nctId":"NCT07094048","phase":"PHASE4","title":"Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager","status":"RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2026-01-05","conditions":"Multiple Myeloma Refractory, Relapsed Multiple Myeloma","enrollment":80},{"nctId":"NCT07221708","phase":"PHASE2, PHASE3","title":"Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-03-01","conditions":"Clostridioides Difficile, Vancomycin Resistance Enterococcus Faecium","enrollment":200},{"nctId":"NCT02129543","phase":"","title":"Immune Reconstitution in Stem Cell Transplant Recipients","status":"RECRUITING","sponsor":"University of Miami","startDate":"2012-08-15","conditions":"Cancer","enrollment":700},{"nctId":"NCT07310797","phase":"PHASE4","title":"Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion","status":"NOT_YET_RECRUITING","sponsor":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","startDate":"2026-01-01","conditions":"Ureteral Calculi","enrollment":500},{"nctId":"NCT06147531","phase":"PHASE2","title":"Delayed Cold-Stored Platelets -PLTS-1","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-06-05","conditions":"Platelets, Bleeding, Cardiopulmonary Bypass","enrollment":150},{"nctId":"NCT05009992","phase":"PHASE2","title":"Combination Therapy for the Treatment of Diffuse Midline Gliomas","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-10-20","conditions":"Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma","enrollment":360},{"nctId":"NCT06384911","phase":"NA","title":"InvesT1D: Promoting Adolescent Investment in Diabetes Care","status":"RECRUITING","sponsor":"Harvard Pilgrim Health Care","startDate":"2024-06-25","conditions":"Type 1 Diabetes","enrollment":96},{"nctId":"NCT07284498","phase":"PHASE4","title":"Treatment of Seizures in Neonate With HIE","status":"NOT_YET_RECRUITING","sponsor":"Mansoura University","startDate":"2026-01-01","conditions":"Neonatal Seizures, HIE - Hypoxic - Ischemic Encephalopathy","enrollment":66},{"nctId":"NCT06717919","phase":"PHASE4","title":"HOPE Against Cancer Recurrence in HCC","status":"RECRUITING","sponsor":"Philipp Dutkowski","startDate":"2025-08-01","conditions":"Liver Transplantation, HCC, Oncological Outcomes","enrollment":220},{"nctId":"NCT07087860","phase":"PHASE2","title":"Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-01","conditions":"Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma","enrollment":70},{"nctId":"NCT07268339","phase":"PHASE3","title":"A Phase III Randomised Control Clinical Trial of Radiotherapy With Radiosensitisation Versus Intravesical Bacillus Calmette-Guerin Therapy for High-risk Non-muscle Invasive Bladder Cancer.","status":"NOT_YET_RECRUITING","sponsor":"The Christie NHS Foundation Trust","startDate":"2025-12-01","conditions":"High-Risk Non-Muscle Invasive Bladder Cancer","enrollment":328},{"nctId":"NCT06587828","phase":"","title":"A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease","status":"RECRUITING","sponsor":"TScan Therapeutics, Inc.","startDate":"2023-01-03","conditions":"Autoimmune Diseases, Ulcerative Colitis, Multiple Sclerosis","enrollment":300},{"nctId":"NCT06683131","phase":"PHASE4","title":"Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2025-11-20","conditions":"Acute Myocardial Infarction (AMI)","enrollment":1160},{"nctId":"NCT04755413","phase":"NA","title":"The Precision CAD Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2022-10-19","conditions":"Coronary Artery Disease","enrollment":276},{"nctId":"NCT06705868","phase":"NA","title":"Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.","status":"NOT_YET_RECRUITING","sponsor":"Cyprus University of Technology","startDate":"2026-01-05","conditions":"MASLD, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, NAFLD","enrollment":150},{"nctId":"NCT05350267","phase":"NA","title":"Changing Health and Lifestyle Behaviors of Offspring Following Maternal Bariatric Surgery","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2022-03-14","conditions":"Obesity, Childhood","enrollment":35},{"nctId":"NCT02735252","phase":"NA","title":"PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2016-05-25","conditions":"Prostate Cancer, Advanced Renal Cell Carcinoma, Advanced Urothelial Carcinoma","enrollment":156},{"nctId":"NCT03767231","phase":"NA","title":"ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-11","conditions":"Hepatitis C","enrollment":200},{"nctId":"NCT05824702","phase":"NA","title":"A Social Network Approach for Improving Medication Assisted Treatment and HIV Prevention and Medical Care Among People Who Inject Drugs in Ukraine","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2023-09-20","conditions":"HIV","enrollment":241},{"nctId":"NCT03192462","phase":"PHASE1, PHASE2","title":"TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer","status":"COMPLETED","sponsor":"Baylor College of Medicine","startDate":"2018-01-18","conditions":"Pancreatic Cancer","enrollment":37},{"nctId":"NCT04130867","phase":"","title":"Rehabilitation Manometry Study","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-11-11","conditions":"Oropharyngeal Dysphagia","enrollment":4},{"nctId":"NCT02711137","phase":"PHASE1, PHASE2","title":"Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2016-05-18","conditions":"Solid Tumors","enrollment":137},{"nctId":"NCT05204719","phase":"NA","title":"Prophylactic DR-CPAP on Late Preterm Infants Born by C-section: an RCT","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oklahoma","startDate":"2023-08-04","conditions":"Premature Birth","enrollment":120},{"nctId":"NCT03520686","phase":"PHASE3","title":"Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ImmunityBio, Inc.","startDate":"2018-05-18","conditions":"Non Small Cell Lung Cancer","enrollment":1538},{"nctId":"NCT03981445","phase":"NA","title":"Integrated HIV Prevention and HCV Care for PWID","status":"ACTIVE_NOT_RECRUITING","sponsor":"Columbia University","startDate":"2019-11-14","conditions":"HIV Prevention, HCV, Opioid Use","enrollment":446},{"nctId":"NCT05101746","phase":"PHASE2, PHASE3","title":"Nitric Oxide Effect on Brain and Kidney in Pediatric Patients Undergoing Cardiopulmonary Bypass","status":"ENROLLING_BY_INVITATION","sponsor":"Vanderbilt University Medical Center","startDate":"2022-04-25","conditions":"Congenital Heart Disease, Congenital Heart Defect, Congenital Heart Malformations","enrollment":50},{"nctId":"NCT04012073","phase":"PHASE3","title":"Individualized Positive End-expiratory Pressure Guided by End-expiratory Lung Volume in the Acute Respiratory Distress Syndrome","status":"TERMINATED","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2022-11-01","conditions":"Respiratory Distress Syndrome, Adult","enrollment":18},{"nctId":"NCT07187284","phase":"PHASE1, PHASE2","title":"EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Zhongda Hospital","startDate":"2025-09-30","conditions":"HCC - Hepatocellular Carcinoma","enrollment":62},{"nctId":"NCT05557292","phase":"PHASE1","title":"RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma","status":"RECRUITING","sponsor":"Nicholas Butowski","startDate":"2023-04-03","conditions":"Glioblastoma, Recurrent Glioblastoma","enrollment":48},{"nctId":"NCT07096687","phase":"NA","title":"Targeted Temperature Management in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Azienda Usl di Bologna","startDate":"2025-09-11","conditions":"Ischemic Stroke","enrollment":22},{"nctId":"NCT07174375","phase":"PHASE2, PHASE3","title":"PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-09-15","conditions":"Acute Ischemic Stroke","enrollment":478},{"nctId":"NCT07056621","phase":"","title":"Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study","status":"RECRUITING","sponsor":"Biomedical Research Foundation, Academy of Athens","startDate":"2025-06-30","conditions":"SLE - Systemic Lupus Erythematosus","enrollment":684},{"nctId":"NCT02905578","phase":"PHASE2","title":"A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)","status":"COMPLETED","sponsor":"Joseph J. Cullen","startDate":"2018-11-28","conditions":"Pancreatic Neoplasms, Cancer of Pancreas, Cancer of the Pancreas","enrollment":40},{"nctId":"NCT07141056","phase":"","title":"The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study","status":"RECRUITING","sponsor":"Guilin Medical University, China","startDate":"2025-01-01","conditions":"HCC - Hepatocellular Carcinoma, Psychological Distress, Immune Checkpoint Inhibitors (ICIs)","enrollment":700},{"nctId":"NCT03232541","phase":"NA","title":"The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting","status":"COMPLETED","sponsor":"Västernorrland County Council, Sweden","startDate":"2017-09-01","conditions":"Breast Cancer, Colorectal Cancer, Bladder Cancer","enrollment":198},{"nctId":"NCT06936709","phase":"PHASE4","title":"Perioperative Colchicine for TKA","status":"NOT_YET_RECRUITING","sponsor":"Geisinger Clinic","startDate":"2025-12-01","conditions":"Osteoarthritis of Knee, Recovery Following Primary Total Knee Arthroplasty, Perioperative Pain Control","enrollment":75},{"nctId":"NCT05325034","phase":"NA","title":"Guideline Oriented Approach To Lipid Lowering In Asia-Pacific","status":"RECRUITING","sponsor":"Stephen Nicholls","startDate":"2022-09-15","conditions":"Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis","enrollment":2000},{"nctId":"NCT07108881","phase":"PHASE4","title":"Ultrasound Guided Fluid Loading Before Spinal Anesthesia","status":"COMPLETED","sponsor":"University Tunis El Manar","startDate":"2024-05-01","conditions":"Cesarean Section Complications, Spinal Anesthesia, Hypotension","enrollment":116},{"nctId":"NCT06940232","phase":"","title":"Validating a Blood Test for the Detection of Traumatic Brain Injury in Children","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2025-05-14","conditions":"Pediatric Traumatic Brain Injury","enrollment":330},{"nctId":"NCT06605430","phase":"PHASE2","title":"Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer","status":"RECRUITING","sponsor":"HealthPartners Institute","startDate":"2024-09-16","conditions":"Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic","enrollment":64},{"nctId":"NCT06346522","phase":"PHASE4","title":"Gabapentin Versus Trospium Chloride for Prevention of a Catheter-related Bladder Discomfort Inside the ICU","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-04-10","conditions":"Catheter-related Bladder Discomfort (CRBD)","enrollment":120},{"nctId":"NCT06929923","phase":"NA","title":"Pro-2-Cool Pivotal Trial II","status":"SUSPENDED","sponsor":"TecTraum Inc.","startDate":"2025-02-20","conditions":"Mild Traumatic Brain Injury","enrollment":72},{"nctId":"NCT03690986","phase":"PHASE1","title":"VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Cancer","status":"RECRUITING","sponsor":"Emory University","startDate":"2018-11-01","conditions":"Squamous Cell Carcinoma of the Head and Neck","enrollment":50},{"nctId":"NCT07064954","phase":"PHASE2, PHASE3","title":"Autologous Cold-stored Apheresis Platelets","status":"NOT_YET_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2025-09-01","conditions":"Bleeding, Platelets, Cardiopulmonary Bypass","enrollment":100},{"nctId":"NCT04624204","phase":"PHASE3","title":"Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-12-08","conditions":"Small Cell Lung Cancer","enrollment":672},{"nctId":"NCT05022823","phase":"NA","title":"Exercise and Compression for Lymphedema","status":"COMPLETED","sponsor":"AHS Cancer Control Alberta","startDate":"2022-06-29","conditions":"Breast Cancer Related Lymphedema","enrollment":40},{"nctId":"NCT04121455","phase":"PHASE1, PHASE2","title":"Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"TME Pharma AG","startDate":"2019-09-12","conditions":"Glioblastoma","enrollment":117},{"nctId":"NCT03704766","phase":"NA","title":"Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis","status":"RECRUITING","sponsor":"Hospital for Special Surgery, New York","startDate":"2016-06-28","conditions":"Joint Infection, Infection of Hip Joint (Disorder), Infection of Shoulder Joint","enrollment":442},{"nctId":"NCT03749499","phase":"NA","title":"Targeting of UnControlled Hypertension in Emergency Department","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2019-02-19","conditions":"Hypertension, Cardiovascular Diseases, Vascular Diseases","enrollment":574},{"nctId":"NCT02205762","phase":"PHASE2, PHASE3","title":"LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis","status":"RECRUITING","sponsor":"North American Consortium for Histiocytosis","startDate":"2016-11-02","conditions":"Langerhans Cell Histiocytosis","enrollment":1400},{"nctId":"NCT06955273","phase":"","title":"Multi-Centre Based Study Recognition of Atrial Fibrillation With the Corsano CardioWatch 287-2 System","status":"NOT_YET_RECRUITING","sponsor":"Corsano Health B.V.","startDate":"2025-05-01","conditions":"Atrial Fibrillation (AF), Paroxysmal Atrial Fibrillation (PAF)","enrollment":350},{"nctId":"NCT06494501","phase":"PHASE3","title":"The Prevent Coronary Artery Disease Trial","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-09-12","conditions":"Atherosclerotic Cardiovascular Disease","enrollment":1600},{"nctId":"NCT04997317","phase":"PHASE1, PHASE2","title":"Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2021-04-21","conditions":"Meningioma","enrollment":18},{"nctId":"NCT06921343","phase":"NA","title":"Iron Deficiency in Pediatric Celiac Disease: Diet vs. Iron Supplementation Trial","status":"NOT_YET_RECRUITING","sponsor":"Kaplan Medical Center","startDate":"2025-04","conditions":"Celiac Disease in Children, Iron Deficiency","enrollment":150},{"nctId":"NCT05081401","phase":"PHASE3","title":"Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2022-05-23","conditions":"Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB","enrollment":1050},{"nctId":"NCT06717854","phase":"NA","title":"Retrograde and Antegrade Enema for Prevention of LARS After LAR: a Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Cancer Hospital and Research Institute","startDate":"2025-03-25","conditions":"Low Anterior Resection Syndrome","enrollment":72},{"nctId":"NCT04924400","phase":"NA","title":"Complete Health Improvement Program for Geisinger Health Plan Members With Type 2 Diabetes","status":"COMPLETED","sponsor":"Thomas Morland","startDate":"2022-03-09","conditions":"Type 2 Diabetes","enrollment":38},{"nctId":"NCT04032106","phase":"NA","title":"HPV Vaccine Intervention for Young Sexual Minority Men","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2019-10-03","conditions":"Healthy Subject","enrollment":1227}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20021104","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19890720","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"20020308","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19881031","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19971029","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19880706","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19910705","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"20150511","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"20161025","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"20020308","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19890720","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"20000310","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19911009","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19741017","type":"ORIG","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19900119","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"20140619","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"20250711","type":"SUPPL","sponsor":"IMPAX LABS","applicationNumber":"ANDA080767"},{"date":"19820527","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20070808","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19980325","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19960919","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20220907","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20070808","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19861015","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19970211","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20200807","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20170201","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19970212","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20171222","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19880825","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20171222","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20150416","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19840614","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19820518","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20170201","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20140227","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19840409","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19820602","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20110408","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20090709","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20130806","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20140227","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19760827","type":"ORIG","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20090506","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19980325","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19970403","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20211022","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19900322","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20031209","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20170201","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20181203","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19880825","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20170201","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19931115","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20170201","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20121127","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20171222","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19840409","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19860211","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20140703","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19840409","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"19820602","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20131226","type":"SUPPL","sponsor":"VIATRIS","applicationNumber":"ANDA084349"},{"date":"20170317","type":"ORIG","sponsor":"AUROBINDO PHARMA","applicationNumber":"ANDA206941"},{"date":"20130116","type":"SUPPL","sponsor":"FOUGERA PHARMS INC","applicationNumber":"NDA021735"},{"date":"20041001","type":"ORIG","sponsor":"FOUGERA PHARMS INC","applicationNumber":"NDA021735"},{"date":"20250822","type":"SUPPL","sponsor":"FOUGERA PHARMS INC","applicationNumber":"NDA021735"},{"date":"20101230","type":"SUPPL","sponsor":"FOUGERA PHARMS INC","applicationNumber":"NDA021735"},{"date":"20140116","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20211029","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20091120","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20090506","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20140116","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"19960313","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20110425","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20091120","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20211029","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"19981027","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20121025","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"19971022","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"20061003","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"19950728","type":"SUPPL","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"},{"date":"19740213","type":"ORIG","sponsor":"PARKE-DAVIS","applicationNumber":"ANDA080258"}],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Group C (\"Standard-of-Care\")","genericName":"Group C (\"Standard-of-Care\")","companyName":"Göteborg University","companyId":"g-teborg-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}